Data Foundry

Drug recalls 2018

Nitrofurantoin Monohydrate/Macrocrystals capsules — Class III drug recall D-0284-2019

Terminated recall by RemedyRepack Inc., reported 2018-12-05, distributed in PA. Cross contamination with other products: Product is being recalled due to the potential presence of unrelated

Recall numberD-0284-2019
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmRemedyRepack Inc., Indiana, PA, United States
Recall initiated2018-11-07
Classified2018-11-27
Reported by FDA2018-12-05
Terminated2019-04-01
DistributedPA
Quantity3,148 capsules
NDC00185-0122-01, 70518-1087-00, 70518-1087-01
Lot numbersB0481339-081018, B0484872-081718, B0506246-092718, B0509938-100418
Expiration dates2019-08, 2019-09, 2019-10

Product

Nitrofurantoin Monohydrate/Macrocrystals capsules,100 mg, packaged in HDPE 60 cc bottles, Rx only, MFG: Sandoz Inc., Princeton, NJ, Repackaged by: RemedyRepack, Indiana, PA, Original NDC 00185-0122-01Repackaged NDC 70518-1087-00, 14 capsules in HDPE 60 cc bottles in cardboard trays & HDPE 60 cc bottles in plastic bags, Repackaged NDC 70518-1087-01, 10 capsules in HDPE 60 cc bottles in cardboard trays.

Reason for recall

Cross contamination with other products: Product is being recalled due to the potential presence of unrelated ingredients (Benazepril, Haloperidol and Perphenazine).

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0284-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.